{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3732, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/2", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/3", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights clinical validation through trial count and patient numbers, alongside key product attributes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/4", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "94c28152-3458-47ee-a77f-de9084897111", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The problem is presented as the need for effective immuno-oncology treatments.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show the status of multiple clinical trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/5", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 4, "beatId": "94c28152-3458-47ee-a77f-de9084897111", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The problem is presented as the need for effective immuno-oncology treatments.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "Uses a process diagram to show the transition from cold to hot tumor states.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/6", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "79775148-8ed0-4b3e-bfb4-2b681b8b32a5", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented as Olvi-Vec, a non-local delivery oncolytic immunotherapy.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "The central diagram illustrates the mechanism of action, contrasting 'Absence of Effector T Cells' (Platinum resistant) with 'Presence of Effector T Cells' (Platinum sensitive).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/7", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "79775148-8ed0-4b3e-bfb4-2b681b8b32a5", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The solution is presented as Olvi-Vec, a non-local delivery oncolytic immunotherapy.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "comparison_table", "function": "compare_peers", "notes": "Uses a pyramid diagram to represent the progression of clinical validation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/8", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "traction", "function": "show_traction", "notes": "The slide compares mPFS results against SOC-AURELIA and ELAHARE benchmarks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/9", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "83a3aa16-5d5b-40f0-bd18-2beeecaa8bff", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction section highlights the results of phase 1b trials and the potential of Olvi-Vec.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "traction", "function": "show_traction", "notes": "The slide outlines the methodology and validation of a clinical trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/10", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-10", "loopMatches": [ { "to": 11, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "74f1324f-3d80-4446-a16d-591787824d08", "evidence": "The loop opens by presenting the challenges of current treatments and closes by showing the benefits of Olvi-Vec.", "position": 0, "objective": "Highlight the cost of not using Olvi-Vec", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "83a3aa16-5d5b-40f0-bd18-2beeecaa8bff", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction section highlights the results of phase 1b trials and the potential of Olvi-Vec.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "key_takeaways", "function": "show_traction", "notes": "The slide uses a table to compare clinical outcomes across patient subgroups (all, resistant, refractory) and a callout box for key takeaways.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/11", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-11", "loopMatches": [ { "to": 11, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "74f1324f-3d80-4446-a16d-591787824d08", "evidence": "The loop opens by presenting the challenges of current treatments and closes by showing the benefits of Olvi-Vec.", "position": 0, "objective": "Highlight the cost of not using Olvi-Vec", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "83a3aa16-5d5b-40f0-bd18-2beeecaa8bff", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction section highlights the results of phase 1b trials and the potential of Olvi-Vec.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "Waterfall plot and spider plot used to visualize clinical efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/12", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "83a3aa16-5d5b-40f0-bd18-2beeecaa8bff", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction section highlights the results of phase 1b trials and the potential of Olvi-Vec.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a before-after comparison structure for three specific patient cases (15B-01, 15B-15, 15B-17).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/13", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "83a3aa16-5d5b-40f0-bd18-2beeecaa8bff", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction section highlights the results of phase 1b trials and the potential of Olvi-Vec.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Includes a Kaplan-Meier plot with a table comparing historical data to VIRO-15 trial results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/14", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "83a3aa16-5d5b-40f0-bd18-2beeecaa8bff", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The traction section highlights the results of phase 1b trials and the potential of Olvi-Vec.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a cross-trial comparison to highlight the efficacy of Olvi-Vec in heavily pre-treated patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/15", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 15, "beatId": "5d6ec1a0-78ec-4c0e-a90d-8d7deda0b64a", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The market size is implied to be large, with a broad and underserved pool of patients.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines a clinical trial protocol for Olvi-Vec in ovarian cancer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/16", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "traction", "function": "show_traction", "notes": "Includes Kaplan-Meier survival curves and dose escalation scatter plots for two distinct patient groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/17", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "Includes specific patient case reports (Pt #21A-06 and Pt #21A-04) showing tumor response metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/18", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "Includes a bio for Benny Li, PhD, CEO of Newsoara.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/19", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights the strategic partnership and the division of commercial rights between Genelux and Newsoara.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/20", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "solution", "function": "present_solution", "notes": "The slide highlights the synergy between two distinct therapeutic approaches (oncolytic immunotherapy and adoptive cell therapy).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/21", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "go_to_market", "function": "plan_implementation", "notes": "The slide uses a hub-and-spoke style layout to categorize strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/22", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-22", "loopMatches": [ { "to": 23, "from": 22, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "61b2324e-9c9a-4af0-b186-77775240e948", "evidence": "The loop opens by presenting the potential for self-launch and closes by highlighting the integrated R&D and manufacturing capabilities.", "position": 1, "objective": "Present a quick win and big bet", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "other", "function": "establish_context", "notes": "The slide uses a document-style callout for key takeaways and circular image containers for facility locations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/23", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-23", "loopMatches": [ { "to": 23, "from": 22, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "61b2324e-9c9a-4af0-b186-77775240e948", "evidence": "The loop opens by presenting the potential for self-launch and closes by highlighting the integrated R&D and manufacturing capabilities.", "position": 1, "objective": "Present a quick win and big bet", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "product_demo", "function": "present_solution", "notes": "The slide categorizes the library into therapeutic genes, immune modularity, and therapeutic antibodies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/24", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "unfair_advantage", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/25", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid layout to present headshots, names, titles, and associated company/institution logos for each team member.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/26", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 26, "beatId": "2a3cbb13-4fbb-4a5c-84ff-e17a1364404f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The team is presented as accomplished and experienced.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "appendix_data", "function": "summarize", "notes": "Includes specific financial metrics and analyst names.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/27", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a dual-track timeline approach: one for executed milestones (left) and one for future goals (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/28", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/29", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/30", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/31", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "traction", "function": "show_traction", "notes": "The slide uses two distinct chart types to show longitudinal dynamics (line chart) and best response (waterfall chart) for the CA-125 biomarker.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/32", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a dual-axis chart to correlate tumor size (SLD) and biomarker (CA-125) response to the Olvi-Vec intervention.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/33", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "key_takeaways", "function": "show_traction", "notes": "Includes histological images of patient samples (Pt.#15A-01 and Pt.#15A-11) showing tumor cell elimination and lymphocyte infiltration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/34", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "traction", "function": "show_traction", "notes": "The slide uses histology images and HALO infiltration histograms to demonstrate the mechanism of action and clinical efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/35", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a combination of immunological data (ELISPOT) and clinical imaging data (SLD) to show causality between immune response and tumor shrinkage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/36", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7d6c-774e-85e8-ffe50da37251", "docSlug": "0b0d701714d17efa78c23c196990e90c", "documentTitle": "Genelux | Investor Presentation Deck | 37 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "solution", "function": "present_solution", "notes": "The slide uses clinical data (cytokine levels and PD-L1 staining) to support the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/37", "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251", "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/XBBVy3s_kNu5IRiTiK5td-m99DAiiJLfbMDfXpGOUZY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MThiM2YxZjgzZWI3MjU5OWEwZjBmZmUyZmFmMGE2ZC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/1", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "56b60c64-d1c4-4f25-8c9e-9515462f8d06", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Q2 2024 Earnings Call, GMS – Q2 FY24 at a Glance", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/40TmUPVrq4fYrs6IqTiUPDUuIdNtCQ0Ojkhn1VkLYVQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MThiM2YxZjgzZWI3MjU5OWEwZjBmZmUyZmFmMGE2ZC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/F4wMbIa7dGDlfoBL2bo57hHhgwpuO0DB1qzdFh0i2rU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MThiM2YxZjgzZWI3MjU5OWEwZjBmZmUyZmFmMGE2ZC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/PmhaHOxAK929XhpLaxdMHgatXRT3_jPpYS4oLKQkoIU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MThiM2YxZjgzZWI3MjU5OWEwZjBmZmUyZmFmMGE2ZC9wMDAxLnBuZw" }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/2", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "56b60c64-d1c4-4f25-8c9e-9515462f8d06", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Q2 2024 Earnings Call, GMS – Q2 FY24 at a Glance", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "kpi_overview", "function": "summarize", "notes": "Includes a disclaimer regarding non-GAAP metrics at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/3", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "56b60c64-d1c4-4f25-8c9e-9515462f8d06", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Q2 2024 Earnings Call, GMS – Q2 FY24 at a Glance", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a four-column layout to detail strategic initiatives and recent progress for each.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/4", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a combination of summary text, callouts for specific financial impacts, and detailed tables for per-day sales and organic growth metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/5", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-5", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "53f95652-8ee4-46c4-b165-fda1e4b07e86", "evidence": "Deflationary Steel Pricing Impacts Profitability, Consolidated GMS Expectations", "position": 0, "objective": "Highlight impact of deflationary steel pricing on profitability and growth priorities", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 6, "from": 5, "beatId": "d695d589-cf88-4bdd-a9b3-260c14a06667", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Solid demand, Deflationary Steel Pricing Impacts Profitability", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a combination of bar charts for absolute dollar values and line charts for percentage margins.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/6", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-6", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "53f95652-8ee4-46c4-b165-fda1e4b07e86", "evidence": "Deflationary Steel Pricing Impacts Profitability, Consolidated GMS Expectations", "position": 0, "objective": "Highlight impact of deflationary steel pricing on profitability and growth priorities", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 6, "from": 5, "beatId": "d695d589-cf88-4bdd-a9b3-260c14a06667", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Solid demand, Deflationary Steel Pricing Impacts Profitability", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes detailing reconciliation and definitions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/7", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-7", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "53f95652-8ee4-46c4-b165-fda1e4b07e86", "evidence": "Deflationary Steel Pricing Impacts Profitability, Consolidated GMS Expectations", "position": 0, "objective": "Highlight impact of deflationary steel pricing on profitability and growth priorities", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide uses a table to compare performance metrics across different product lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/8", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-8", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "53f95652-8ee4-46c4-b165-fda1e4b07e86", "evidence": "Deflationary Steel Pricing Impacts Profitability, Consolidated GMS Expectations", "position": 0, "objective": "Highlight impact of deflationary steel pricing on profitability and growth priorities", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes regarding reconciliation and tax rate definitions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/9", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-9", "loopMatches": [ { "to": 9, "from": 5, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "53f95652-8ee4-46c4-b165-fda1e4b07e86", "evidence": "Deflationary Steel Pricing Impacts Profitability, Consolidated GMS Expectations", "position": 0, "objective": "Highlight impact of deflationary steel pricing on profitability and growth priorities", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 9, "beatId": "d5528296-9666-4e96-a39b-019e0b528ea7", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Consolidated GMS Expectations for Q3 FY24 and Full Year Fiscal 2024", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/10", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes operational metrics like branch count and net sales per business day.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/11", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes supplemental cash flow disclosures and a non-GAAP reconciliation for free cash flow.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/12", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table includes a footnote explaining the organic net sales growth calculation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/13", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table includes a breakdown of adjustments (A-H) with corresponding footnotes on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/14", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes detailed line-item adjustments (A-J) with corresponding commentary.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/15", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes A and B explaining specific adjustments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/16", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a commentary section explaining the nature of the adjustments (A-E).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/17", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes regarding unamortized discounts and deferred financing costs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/18", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e02-7709-910f-c8a110eda1e7", "docSlug": "418b3f1f83eb72599a0f0ffe2faf0a6d", "documentTitle": "GMS | Results Presentation Deck | 19 slides", "authorId": "gms", "authorName": "GMS", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e02-7709-910f-c8a110eda1e7/19", "deckHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7", "deckAnchorHref": "/decks/019de076-7e02-7709-910f-c8a110eda1e7#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5", "docSlug": "225408061c3ed04b028031d27cf2467f", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides", "authorId": "immix-biopharma", "authorName": "ImmixBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes date and ticker symbol.", "imagePath": "https://imgproxy.kitesheet.com/nCbeg7yVde1POrk5RMQANsrBv-YkS61FNoSeAuU976o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjU0MDgwNjFjM2VkMDRiMDI4MDMxZDI3Y2YyNDY3Zi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/1", "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5", "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "42173db8-f556-4038-8cd7-f027f3f404dc", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document provides an overview of Immix Biopharma and its technology.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/NrsRqOZeuBDMp8WlYNJzytOHY6kCMkS2bH2UAXB0qv4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjU0MDgwNjFjM2VkMDRiMDI4MDMxZDI3Y2YyNDY3Zi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/nGOZ56Vr4-deG54nTi9knCSXIGXLF6n-dQb989qkne0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjU0MDgwNjFjM2VkMDRiMDI4MDMxZDI3Y2YyNDY3Zi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/TTKm3urD1BMupYgzEt3krfhRP494Gg-DliOUd6rGGFY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjU0MDgwNjFjM2VkMDRiMDI4MDMxZDI3Y2YyNDY3Zi9wMDAxLnBuZw" }, { "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5", "docSlug": "225408061c3ed04b028031d27cf2467f", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides", "authorId": "immix-biopharma", "authorName": "ImmixBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/2", "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5", "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "42173db8-f556-4038-8cd7-f027f3f404dc", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document provides an overview of Immix Biopharma and its technology.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5", "docSlug": "225408061c3ed04b028031d27cf2467f", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides", "authorId": "immix-biopharma", "authorName": "ImmixBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a numbered list format to present key value propositions for investors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/3", "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5", "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "42173db8-f556-4038-8cd7-f027f3f404dc", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document provides an overview of Immix Biopharma and its technology.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5", "docSlug": "225408061c3ed04b028031d27cf2467f", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides", "authorId": "immix-biopharma", "authorName": "ImmixBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid-based layout to categorize team members into three distinct groups: Leadership, Board of Directors, and Scientific Advisory Board.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/4", "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5", "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "42173db8-f556-4038-8cd7-f027f3f404dc", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document provides an overview of Immix Biopharma and its technology.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-7e9d-767a-a7eb-99a77c1645c5", "docSlug": "225408061c3ed04b028031d27cf2467f", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 62 slides", "authorId": "immix-biopharma", "authorName": "ImmixBio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a causal-chain framework to link platform capabilities to strategic outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-7e9d-767a-a7eb-99a77c1645c5/5", "deckHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5", "deckAnchorHref": "/decks/019de076-7e9d-767a-a7eb-99a77c1645c5#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "42173db8-f556-4038-8cd7-f027f3f404dc", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "The document provides an overview of Immix Biopharma and its technology.", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }